Lys102
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.5
Powered by Cell Signaling Technology
Home > Sumoylation Site Page: > Lys102  -  Nur77 (human)

Site Information
sPASASFkFEDFQVY   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 610814562

In vivo Characterization
Methods used to characterize site in vivo:
immunoprecipitation ( 2 ) , mutation of modification site ( 2 ) , western blotting ( 2 )
Disease tissue studied:
leukemia ( 2 ) , acute myelogenous leukemia ( 2 )
Relevant cell line - cell type - tissue:
HEK293T (epithelial) ( 2 ) , HeLa (cervical) ( 2 ) , THP1 (myeloid) ( 2 )

Upstream Regulation
Regulatory protein:
SENP1 (human) ( 2 )
Treatments:
phorbol_ester ( 2 )

Downstream Regulation
Effects of modification on Nur77:
protein degradation ( 2 ) , ubiquitination ( 2 )
Effects of modification on biological processes:
transcription, inhibited ( 2 )

References 

1

Lumpkin RJ, et al. (2017) Site-specific identification and quantitation of endogenous SUMO modifications under native conditions. Nat Commun 8, 1171
29079793   Curated Info

2

Zhang L, et al. (2017) SUMO-triggered ubiquitination of NR4A1 controls macrophage cell death. Cell Death Differ 24, 1530-1539
28622293   Curated Info

Developed with grants from  NIH Logo and literature mining with Linguamatics  I2E Logo Creative Commons License PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.

©2003-2024 Cell Signaling Technology, Inc.